According to Regeneron Pharmaceuticals's latest financial reports the company's current revenue (TTM ) is ₹1.175 Trillion. In 2023 the company made a revenue of ₹1.091 Trillion an increase over the revenue in the year 2022 that were of ₹1.007 Trillion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.